RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas

Abstract

The RAS/MAPK and PI3K/mTOR pathways are activated in the majority of cases of UPS. The RAS/MAPK pathway distinguishes a subgroup of patients with localized UPS with a worse outcome.